Market

• U.S. sales of drugs using advanced drug delivery technology totaled approximately $25 billion in 2007. We believe that ITI’s product portfolio addresses a significant subsegment of that market.
• Likely factors driving the demand for technologies such as nasal drug delivery include drug development costs, loss of patent protection for prescription drugs, and robust biotechnology pipelines that can benefit from alternatives to traditional injection methods.
• Demographic trends and a move toward managed care and home care are expected to help encourage the use of effective, easy-to-use forms of patient-administered prescription medication. Nasal delivery technologies help ensure patient compliance and could possibly help lower overall treatment costs.
• Nasal delivery already is accepted among many patients and health care professionals as an effective drug delivery alternative, as evidenced by available over-the-counter products and a growing number of nasally delivered prescription products.